*Nasdaq FSI: *Deficient: Issuer Failed to Meet NASDAQ Continued Listing Requirements
The Oncology Institute, Inc. is a value-based oncology company. The Company manages community-based oncology practices that serve patients at approximately 76 clinic locations across 15 markets and five states throughout the United States. The Company's segment includes dispensary, patient care, and clinical trials & other. Its managed clinics provide a range of medical oncology services, including physician services, in-house infusion and dispensary, clinical trial services, radiation, programs like outpatient blood product transfusions, along with 24/7 patient support. The Company, through TOI Clinical Research, LLC (TCR), provides and manages clinical trial services and research for the benefit of cancer patients. The Company also provides management services to 14 clinic locations owned by independent oncology practices. The Company's managed clinics primarily serve adult and senior cancer patients in markets that have Medicare Advantage (MA) plans.
Options are not suitable for all investors as the special risks inherent to options trading may
expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.
Copyright © 2023. All rights reserved.